Alpine Global Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-33,812
| Closed | -$61.9K | – | 194 |
|
|
2024
Q4 | $61.9K | Buy |
+33,812
| New | +$61.9K | 0.01% | 202 |
|
|
2024
Q3 | – | Sell |
-24,916
| Closed | -$201K | – | 296 |
|
|
2024
Q2 | $201K | Buy |
+24,916
| New | +$201K | 0.04% | 307 |
|
|
2023
Q1 | – | Sell |
-6,348
| Closed | -$119K | – | 288 |
|
|
2022
Q4 | $119K | Buy |
+6,348
| New | +$119K | 0.04% | 173 |
|
|
2022
Q1 | – | Sell |
-1,437
| Closed | -$86K | – | 578 |
|
|
2021
Q4 | $86K | Buy |
+1,437
| New | +$86K | 0.01% | 690 |
|
|
2020
Q4 | – | Sell |
-1,667
| Closed | -$232K | – | 252 |
|
|
2020
Q3 | $232K | Buy |
+1,667
| New | +$232K | 0.05% | 146 |
|
|
2014
Q2 | – | Sell |
-322
| Closed | -$51K | – | 193 |
|
|
2014
Q1 | $51K | Buy |
+322
| New | +$51K | 0.04% | 140 |
|